S&P 500   3,962.99 (+0.66%)
DOW   32,181.11 (+0.47%)
QQQ   311.22 (+1.67%)
AAPL   159.55 (+1.09%)
MSFT   278.95 (+2.45%)
META   205.66 (+2.93%)
GOOGL   105.73 (+2.28%)
AMZN   99.32 (+0.63%)
TSLA   191.94 (+0.41%)
NVDA   271.65 (+2.63%)
NIO   9.30 (+2.31%)
BABA   86.45 (+3.35%)
AMD   100.92 (+3.42%)
T   18.48 (+0.49%)
F   11.55 (+0.61%)
MU   61.45 (+5.64%)
CGC   1.92 (+1.86%)
GE   91.39 (+2.01%)
DIS   96.40 (+1.58%)
AMC   4.43 (+2.07%)
PFE   40.27 (+0.65%)
PYPL   73.03 (-1.76%)
NFLX   317.75 (+8.12%)
S&P 500   3,962.99 (+0.66%)
DOW   32,181.11 (+0.47%)
QQQ   311.22 (+1.67%)
AAPL   159.55 (+1.09%)
MSFT   278.95 (+2.45%)
META   205.66 (+2.93%)
GOOGL   105.73 (+2.28%)
AMZN   99.32 (+0.63%)
TSLA   191.94 (+0.41%)
NVDA   271.65 (+2.63%)
NIO   9.30 (+2.31%)
BABA   86.45 (+3.35%)
AMD   100.92 (+3.42%)
T   18.48 (+0.49%)
F   11.55 (+0.61%)
MU   61.45 (+5.64%)
CGC   1.92 (+1.86%)
GE   91.39 (+2.01%)
DIS   96.40 (+1.58%)
AMC   4.43 (+2.07%)
PFE   40.27 (+0.65%)
PYPL   73.03 (-1.76%)
NFLX   317.75 (+8.12%)
S&P 500   3,962.99 (+0.66%)
DOW   32,181.11 (+0.47%)
QQQ   311.22 (+1.67%)
AAPL   159.55 (+1.09%)
MSFT   278.95 (+2.45%)
META   205.66 (+2.93%)
GOOGL   105.73 (+2.28%)
AMZN   99.32 (+0.63%)
TSLA   191.94 (+0.41%)
NVDA   271.65 (+2.63%)
NIO   9.30 (+2.31%)
BABA   86.45 (+3.35%)
AMD   100.92 (+3.42%)
T   18.48 (+0.49%)
F   11.55 (+0.61%)
MU   61.45 (+5.64%)
CGC   1.92 (+1.86%)
GE   91.39 (+2.01%)
DIS   96.40 (+1.58%)
AMC   4.43 (+2.07%)
PFE   40.27 (+0.65%)
PYPL   73.03 (-1.76%)
NFLX   317.75 (+8.12%)
S&P 500   3,962.99 (+0.66%)
DOW   32,181.11 (+0.47%)
QQQ   311.22 (+1.67%)
AAPL   159.55 (+1.09%)
MSFT   278.95 (+2.45%)
META   205.66 (+2.93%)
GOOGL   105.73 (+2.28%)
AMZN   99.32 (+0.63%)
TSLA   191.94 (+0.41%)
NVDA   271.65 (+2.63%)
NIO   9.30 (+2.31%)
BABA   86.45 (+3.35%)
AMD   100.92 (+3.42%)
T   18.48 (+0.49%)
F   11.55 (+0.61%)
MU   61.45 (+5.64%)
CGC   1.92 (+1.86%)
GE   91.39 (+2.01%)
DIS   96.40 (+1.58%)
AMC   4.43 (+2.07%)
PFE   40.27 (+0.65%)
PYPL   73.03 (-1.76%)
NFLX   317.75 (+8.12%)
NASDAQ:EYPT

EyePoint Pharmaceuticals - EYPT Insider Trading & Ownership

$2.32
-0.07 (-2.93%)
(As of 03/23/2023 01:55 PM ET)
Add
Compare
Today's Range
$2.29
▼
$2.49
50-Day Range
$2.35
▼
$5.04
52-Week Range
$2.19
▼
$13.18
Volume
132,265 shs
Average Volume
286,776 shs
Market Capitalization
$79.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.00

EyePoint Pharmaceuticals (NASDAQ:EYPT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.88%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
0

EYPT Insider Buying and Selling by Quarter

Get EYPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling EyePoint Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

EyePoint Pharmaceuticals Insider Trades History

Export to Excel
(Data available from 1/1/2013 forward)












EYPT Insider Trading Activity - Frequently Asked Questions

Who is on EyePoint Pharmaceuticals's Insider Roster?

The list of insiders at EyePoint Pharmaceuticals includes George Elston. Learn more on insiders at EYPT.

What percentage of EyePoint Pharmaceuticals stock is owned by insiders?

11.88% of EyePoint Pharmaceuticals stock is owned by insiders. Learn more on EYPT's insider holdings.

This page (NASDAQ:EYPT) was last updated on 3/23/2023 by MarketBeat.com Staff